Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Woerns, Marcus-Alexander; Galle, Peter R.
HEPATOCELLULAR CARCINOMA IN 2017 Two large steps forward, one small step backNATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY. Bd. 15. H. 2. 2018 S. 75-76
Foerster, Friedrich; Galle, Peter Robert
Hepatocellular carcinoma: one world, one cancer-different guidelines?HEPATOBILIARY SURGERY AND NUTRITION. Bd. 7. H. 1. 2018 S. 41-43
Gehrke, Nadine; Hoevelmeyer, Nadine; Waisman, Ari et al.
Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammationJOURNAL OF HEPATOLOGY. Bd. 68. H. 5. 2018 S. 986-995
Worns, Marcus-Alexander; Galle, Peter Robert
Hepatology Snapshot: Patient prioritisation in HCC treatment: All (good) things come in threesJOURNAL OF HEPATOLOGY. Bd. 68. H. 6. 2018 S. 1311-1312
Weinmann-Menke, J.; Weinmann, A.; Lutz, J.
Hepatorenal syndromeNEPHROLOGE. Bd. 13. H. 4. 2018 S. 277-286
Sprinzl, Martin; Kremer, Maximilian; Kohlwes, Elke et al.
HIGH-INTENSITY CONTRAST IMAGING ASSISTED HIGH-RESOLUTION ANOSCOPY WITH BLUE LIGHT IMAGING (BLI) FOR ANAL CARCINOMA SCREENING IN HIV INFECTED PATIENTSGASTROINTESTINAL ENDOSCOPY. Bd. 87. H. 6. 2018 S. AB381-AB381
Hopprich, Anne; Reinholz, Ulrike; Gerlach, Christina et al.
How to Identify the Inpatient's Palliative Care Needs in a Hemato-Oncological Ward: Ask the Nurses!JOURNAL OF PALLIATIVE MEDICINE. Bd. 21. H. 1. 2018 S. 4-5
Zhong, Xiaoxia; Prinz, Andreas; Steger, Julia et al.
HoxA9 transforms murine myeloid cells by a feedback loop driving expression of key oncogenes and cell cycle control genesBLOOD ADVANCES. Bd. 2. H. 22. 2018 S. 3137-3148
Holmer, Amadeus; Marotz, Joerg; Wahl, Philip et al.
Hyperspectral imaging in perfusion and wound diagnostics - methods and algorithms for the determination of tissue parametersBIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK. Bd. 63. H. 5. 2018 S. 547-556
Gopal, Ajay K.; Schuster, Stephen J.; Fowler, Nathan H. et al.
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN StudyJOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 23. 2018 S. 2405-+